OSTEOARTHRITIS OF THE KNEES
Clinical trials for OSTEOARTHRITIS OF THE KNEES explained in plain language.
Never miss a new study
Get alerted when new OSTEOARTHRITIS OF THE KNEES trials appear
Sign up with your email to follow new studies for OSTEOARTHRITIS OF THE KNEES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New knee osteoarthritis drug AD-211 enters phase 2 trial
Symptom relief Not yet recruitingThis study tests a new drug called AD-211 to find the best dose for easing knee pain from osteoarthritis. About 200 people with knee osteoarthritis will take part in this double-blind, placebo-controlled trial. The main goal is to measure pain reduction during activity over 24 ho…
Matched conditions: OSTEOARTHRITIS OF THE KNEES
Phase: PHASE2 • Sponsor: Addpharma Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New knee pain drug enters human testing
Symptom relief Not yet recruitingThis early-stage study tests a drug called CX-011 for moderate to severe knee osteoarthritis pain. About 72 adults aged 18-75 with knee osteoarthritis will receive the drug via injection into the knee joint. The main goals are to check safety and tolerability, and to see if it re…
Matched conditions: OSTEOARTHRITIS OF THE KNEES
Phase: PHASE1, PHASE2 • Sponsor: CarthroniX, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC